USCOM LIMITED — Regulatory Filings 2014

Mar 9, 2014

Uscom Limited ABN 35 091 028 090 Suite 1, Level 7, 10 Loftus Street Sydney NSW 2000 Australia T +612 9247 4144 F +612 9247 8157 www.uscom.com.au

==> picture [57 x 49] intentionally omitted <==

M A R K E T A N N O U N C E M E N T

Uscom appoints new Scandinavian distributor

Monday 10th of March 2014: Uscom (ASX code: UCM)

Uscom Limited is pleased to announce the appointment of Avalon Medical AS as an USCOM 1A distributor for the Norway and Sweden markets for 3 years.

Avalon Medical was established in 1997 and operates as a sub-distributor into the Norwegian and Swedish markets for sophisticated medical devices. The Company specialises in high end patient monitoring devices from manufacturers including Welch Allyn, Nihon Kohden and Heinen & Lowenstein, with a focus on the anaesthesia, neonatology and patient monitoring markets. The Company has a number of product specialists with ultrasound and haemodynamics experience in cardiovascular monitoring.

The Norwegian Healthcare budget is the second highest per capita in the world, spending approximately 9.3% of GDP on Healthcare. The Norwegian and Swedish medical device market services approximately 15m people.

Executive Chairman of Uscom, Rob Phillips said, “We are pleased to welcome Avalon Medical to our expanding distribution network. They are a smart company with an established market presence in Norway and Sweden and see value and opportunity in delivering our USCOM 1A into this wealthy market. Norway has a long history with Doppler technologies and we expect a rapid recognition and adoption of our innovative Doppler device.”

Uscom manufactures and markets the USCOM 1A and the Uscom BP+, both premium cardiovascular devices changing the way we diagnose and treat circulatory disease, including hypertension, heart failure and sepsis. The two products are also integral for optimising cardiovascular management and guidance of fluid, inotropes and vasoactive therapies.

About Uscom

Uscom Limited is an ASX listed cardiovascular medical device company (UCM). Uscom is an innovative developer and manufacturer of premium cardiovascular devices and has two practice leading technologies in the field of cardiovascular monitoring, the USCOM 1A and the BP+. The devices are both clinically validated with FDA, CE and TGA regulatory approval, and are currently being marketed into global distribution networks.

The USCOM 1A is a simple, cost-effective and non-invasive device that measures heart function, detects irregularities and guides treatment. The USCOM device has major applications in Paediatrics, Emergency, Intensive Care Medicine and Anesthesia, and is the device of choice for management of adult and paediatric sepsis, and for the guidance of fluid therapy.

The Uscom BP+ is a supra systolic Central Blood Pressure monitor and replaces older and more widespread BP sub systolic Blood Pressure monitoring technology. Central Blood Pressure is becoming the new standard of care measurement in hypertension and heart failure. The Uscom BP+ provides a highly accurate and repeatable measurement of central and brachial blood pressure and pulse pressure waveforms using a familiar upper arm cuff. The BP+ is simple to use and requires no complex training with applications in cardiology, intensive care, general practice and home care.

For more information, please visit: http://www.uscom.com.au

Uscom Contacts Rob Phillips Executive Chairman rob@uscom.com.au

Catherine Officer Company Secretary secretary@uscom.com.au